| Date Filed | Type | Description |
| 02/01/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/15/2013 |
SC 13G
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 7.4% stake in Interleukin Genetics, Inc. |
| 02/08/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/08/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/08/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/08/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/26/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/31/2011 |
SC 13G
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 5.6% stake in Fibrocell Science, Inc. |
| 08/11/2011 |
SC 13D/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 8.5% stake in ICAGEN, INC. |
| 07/29/2011 |
SC 13D
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 10% stake in ICAGEN, INC. |
| 05/23/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/26/2010 |
SC 13G
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 5.8% stake in Ziopharm Oncology, Inc. |
| 01/26/2010 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 13.1% stake in Sunesis Pharmaceuticals Inc. |
| 01/26/2010 |
SC 13G/A
| MICROMET, INC. reports a 4.5% stake in Micromet Inc. |
| 01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 04/14/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 01/30/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/30/2009 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 6.5% stake in Micromet Inc. |
| 01/30/2009 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 6.3% stake in Genelabs Technologies Inc. |
| 01/30/2009 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 0% stake in Pharmacopeia Inc. |